These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 36035063)

  • 41. Severe sinus bradycardia associated with favipiravir in a COVID-19 patient.
    Habib MB; Elshafei M; Rahhal A; Mohamed MFH
    Clin Case Rep; 2021 Aug; 9(8):e04566. PubMed ID: 34401155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
    Payus AO; Chai AC; Mustafa N
    Clin Case Rep; 2021 Aug; 9(8):e04678. PubMed ID: 34430027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correction to "Complicated appendicitis, acute pancreatitis, pleural effusion, and sinus bradycardia in a COVID-19 patient".
    Clin Case Rep; 2023 Nov; 11(11):e8196. PubMed ID: 38028091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relative bradycardia in patients with COVID-19.
    Jung LY; Kim JM; Ryu S; Lee CS
    Int J Arrhythmia; 2022; 23(1):22. PubMed ID: 36065390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remdesivir-Induced Bradycardia and Mortality in SARS-CoV-2 Infection, Potential Risk Factors Assessment: A Systematic Review and Meta-Analysis.
    Ai MY; Chang WL; Yang CJ
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137586
    [No Abstract]   [Full Text] [Related]  

  • 46. Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.
    Ahmed T; Lodhi SH; Ahmed T
    Cureus; 2022 Jul; 14(7):e27249. PubMed ID: 36035063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report.
    Guziejko K; Talalaj J; Chorazy M; Groth M; Moniuszko-Malinowska A
    Infection; 2022 Dec; 50(6):1605-1613. PubMed ID: 35701724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study.
    Hajimoradi M; Sharif Kashani B; Dastan F; Aghdasi S; Abedini A; Naghashzadeh F; Mohamadifar A; Keshmiri MS; Noorali S; Lookzadeh S; Alizadeh N; Siri MA; Tavasolpanahi M; Abdolmohammadi Y; Shafaghi M; Rouhani ZS; Shafaghi S
    Front Pharmacol; 2022; 13():1107198. PubMed ID: 36733376
    [No Abstract]   [Full Text] [Related]  

  • 49. Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19.
    Wasef N; Hamilton S; Fatima T; Osgood E
    Cureus; 2022 Jul; 14(7):e27307. PubMed ID: 35910702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre.
    Bistrovic P; Manola S; Lucijanic M
    Postgrad Med J; 2022 Jul; 98(1161):501-502. PubMed ID: 34876485
    [No Abstract]   [Full Text] [Related]  

  • 51. Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.
    Attena E; Albani S; Maraolo AE; Mollica M; De Rosa A; Pisapia R; Fiorentino G; Parrella R; Severino S; Russo V
    Circ Arrhythm Electrophysiol; 2021 Jul; 14(7):e009811. PubMed ID: 34182791
    [No Abstract]   [Full Text] [Related]  

  • 52. Cardiac Adverse Events With Remdesivir in COVID-19 Infection.
    Gupta AK; Parker BM; Priyadarshi V; Parker J
    Cureus; 2020 Oct; 12(10):e11132. PubMed ID: 33240723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review.
    Gubitosa JC; Kakar P; Gerula C; Nossa H; Finkel D; Wong K; Khatri M; Ali H
    JACC Case Rep; 2020 Nov; 2(14):2260-2264. PubMed ID: 33163977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compassionate Use of Remdesivir for Patients with Severe Covid-19.
    Grein J; Ohmagari N; Shin D; Diaz G; Asperges E; Castagna A; Feldt T; Green G; Green ML; Lescure FX; Nicastri E; Oda R; Yo K; Quiros-Roldan E; Studemeister A; Redinski J; Ahmed S; Bernett J; Chelliah D; Chen D; Chihara S; Cohen SH; Cunningham J; D'Arminio Monforte A; Ismail S; Kato H; Lapadula G; L'Her E; Maeno T; Majumder S; Massari M; Mora-Rillo M; Mutoh Y; Nguyen D; Verweij E; Zoufaly A; Osinusi AO; DeZure A; Zhao Y; Zhong L; Chokkalingam A; Elboudwarej E; Telep L; Timbs L; Henne I; Sellers S; Cao H; Tan SK; Winterbourne L; Desai P; Mera R; Gaggar A; Myers RP; Brainard DM; Childs R; Flanigan T
    N Engl J Med; 2020 Jun; 382(24):2327-2336. PubMed ID: 32275812
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.